Drug
Gemcitabine and nab-paclitaxel
Gemcitabine and nab-paclitaxel is a pharmaceutical drug with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
2(67%)
Phase Distribution
Ph phase_1
3
100%
Phase Distribution
3
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
3(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Other(1)
Detailed Status
Active, not recruiting1
Suspended1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
Phase 1
Trials by Phase
Phase 13 (100.0%)
Trials by Status
active_not_recruiting133%
suspended133%
recruiting133%
Recent Activity
2 active trials
Showing 3 of 3
active_not_recruitingphase_1
A Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep and Atezolizumab
NCT07280377
recruitingphase_1
A 2-part Phase 1/2 Open-label Trial on ODM-212
NCT07563738
suspendedphase_1
A Study of ABTL0812 in Pancreatic Cancer
NCT03417921
Clinical Trials (3)
Showing 3 of 3 trials
NCT07280377Phase 1
A Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep and Atezolizumab
NCT07563738Phase 1
A 2-part Phase 1/2 Open-label Trial on ODM-212
NCT03417921Phase 1
A Study of ABTL0812 in Pancreatic Cancer
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3